NEW YORK, Aug 10 (Reuters) – Hims & Hers Health on Monday posted a bigger-than-expected second-quarter loss as the telehealth company's shift to branded weight-loss drugs drove up costs. Shares of the
(The article has been published through a syndicated feed. Except for the headline, the content has been published verbatim. Liability lies with original publisher.)
US SEC exempts certain data center bonds from key securitization rules
Aug 10 (Reuters) - The U.S. Securities and Exchange Commission has made it easier for…
Masters, National Bank Open presented by Rogers Men's Singles Final Rounds and Seeds Progress
Aug 10 (OPTA) - Final Rounds and Seeds Progress from the Masters, National Bank Open…
US court rules Meta, other tech firms must face thousands of lawsuits over social media addiction
By Diana Novak Jones Aug 10 (Reuters) - A U.S. appeals court on Monday allowed…
